World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
59
Citations
13446
World Ranking
3255
National Ranking
1286

Overview

Arthur L. Barry is a researcher affiliated with the University of California, Davis in the United States. Their work spans multiple disciplines, primarily focused on medicine and environmental science.

Barry's publication record includes research related to advanced breast cancer therapies and environmental applications concerning building energy and urban health. Their recent papers illustrate this interdisciplinary approach.

  • "339P A United Kingdom (UK) physician survey to assess biomarker (BM) testing patterns in patients with metastatic breast cancer (mBC) and physician access to prescribing fulvestrant," 2025, published in ESMO Open
  • "Beyond the Light Meter: A Case-Study on HDR-Derived Illuminance Calculations Using a Proxy-Lambertian Surface," 2025, published in Buildings

The venues where Barry frequently publishes reflect their dual focus areas and include:

  • ESMO Open
  • Buildings

The research fields covered by their work mainly include Medicine and Environmental Science, with specific subfields such as Pulmonary and Respiratory Medicine, Oncology, Building and Construction, Environmental Engineering, and Health, Toxicology and Mutagenesis.

Barry's topical expertise is evident in their engagement with:

  • Advanced Breast Cancer Therapies
  • Cancer Treatment and Pharmacology
  • Building Energy and Comfort Optimization
  • Urban Heat Island Mitigation
  • Urban Green Space and Health

Their collaborative network shows frequent co-authors involved in related research areas, including:

  • A. Lad
  • C. Doody
  • Roma Parikh
  • María I. Jiménez
  • Jackson Hanus

Best Publications

  • Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

    John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett

  • Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.

    J H Rex;M A Pfaller;A L Barry;P W Nelson

  • The antimicrobic susceptibility test : principles and practices

    Arthur L. Barry;Paul D. Hoeprich;Michael A. Saubolle

  • Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents

    A. L. Barry;M. A. Pfaller;S. D. Brown;A. Espinel-Ingroff

  • Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

    A L Barry;R N Jones;C Thornsberry;L W Ayers

  • Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus.

    W. Lawrence Drew;A. L. Barry;Richard O'Toole;John C. Sherris

  • In Vitro Activities of Daptomycin against 2,789 Clinical Isolates from 11 North American Medical Centers

    Arthur L. Barry;Peter C. Fuchs;Steven D. Brown

  • An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens.

    Unknown

  • In vitro bactericidal activity of daptomycin against staphylococci

    Peter C. Fuchs;Arthur L. Barry;Steven D. Brown

  • Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

    Peter C. Fuchs;Arthur L. Barry;Steven D. Brown

  • Collaborative Evaluation of a Proposed Reference Dilution Method of Susceptibility Testing of Anaerobic Bacteria

    Vera L. Sutter;Arthur L. Barry;Tracy D. Wilkins;Ronald J. Zabransky

  • In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993

    Unknown

  • Methods of measuring zones of inhibition with the Bauer-Kirby disk susceptibility test.

    A L Barry;M B Coyle;C Thornsberry;E H Gerlach

  • Fluconazole disk diffusion procedure for determining susceptibility of Candida species

    Unknown

  • Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

    T L Gavan;R N Jones;A L Barry;P C Fuchs

  • In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin.

    A L Barry;R N Jones;C Thornsberry

  • Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendations

    Ronald N. Jones;Arthur L. Barry

  • In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers

    Peter C. Fuchs;Arthur L. Barry;Steven D. Brown

  • In-vitro studies of meropenem.

    Ronald N. Jones;Arthur L. Barry;Clyde Tbornsberry

  • Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests

    R N Jones;A L Barry;C Thornsberry;E H Gerlach

  • Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.

    Arthur L. Barry;Ronald N. Jones

  • In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog

    Peter C. Fuchs;Arthur L. Barry;Steven D. Brown

  • Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy

    Ronald N. Jones;Arthur L. Barry;Clyde Thornsberry

Frequent Co-Authors

Clyde Thornsberry
Clyde Thornsberry Centers for Disease Control and Prevention
Ronald N. Jones
Ronald N. Jones JMI Laboratories
James H. Jorgensen
James H. Jorgensen The University of Texas Health Science Center at San Antonio
Fred C. Tenover
Fred C. Tenover University of Dayton
John A. Washington
John A. Washington Cleveland Clinic
L. B. Reller
L. B. Reller Duke University
Lance R. Peterson
Lance R. Peterson NorthShore University HealthSystem
Tracy D. Wilkins
Tracy D. Wilkins Virginia Tech
James H. Jorgensen
James H. Jorgensen The University of Texas Health Science Center at San Antonio
Hannah M. Wexler
Hannah M. Wexler University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology can open diverse career paths, many of which intersect with healthcare and information management. For those interested in combining clinical expertise with a holistic approach, functional medicine nurse practitioner programs offer specialized training that integrates microbiology knowledge with patient care.

Alternatively, for individuals inclined towards the administrative and technological side of healthcare, careers in medical coding and health information management are promising options. Certified Professional Coders enjoy competitive cpc medical coding salary prospects while playing a crucial role in healthcare documentation.

Health information managers, who oversee medical data quality and security, also benefit from strong job growth and competitive pay, as detailed in the health information management degree salary analysis.

Students looking to advance in this field can explore flexible learning through an online cahiim accredited health information management degree. These accredited programs ensure quality education that aligns with industry standards, preparing graduates for impactful careers.

Best Scientists Citing Arthur L. Barry